Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFAZOLIN Cause Activated partial thromboplastin time prolonged? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Activated partial thromboplastin time prolonged have been filed in association with CEFAZOLIN (Cefazolin). This represents 0.1% of all adverse event reports for CEFAZOLIN.

5
Reports of Activated partial thromboplastin time prolonged with CEFAZOLIN
0.1%
of all CEFAZOLIN reports
0
Deaths
3
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From CEFAZOLIN?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFAZOLIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does CEFAZOLIN Cause?

Anaphylactic shock (490) Anaphylactic reaction (429) Rash (415) Hypotension (394) Drug ineffective (344) Drug hypersensitivity (315) Urticaria (262) Erythema (187) Tachycardia (170) Pruritus (168)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which CEFAZOLIN Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

CEFAZOLIN vs CEFDINIR CEFAZOLIN vs CEFEPIME CEFAZOLIN vs CEFEPIME\CEFEPIME CEFAZOLIN vs CEFIDEROCOL CEFAZOLIN vs CEFIXIME

Related Pages

CEFAZOLIN Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged CEFAZOLIN Demographics